Literature DB >> 2455710

Structures of the sugar chains of recombinant human granulocyte-colony-stimulating factor produced by Chinese hamster ovary cells.

M Oheda1, S Hase, M Ono, T Ikenaka.   

Abstract

Recombinant human granulocyte-colony-stimulating factor (G-CSF) was purified from Chinese hamster ovary cells transfected with human G-CSF cDNA. The recombinant human G-CSF was treated with alkaline borohydride and the oligosaccharide-alditols liberated were fractioned by gel filtration on a Bio-Gel P-4 column, followed by high-performance liquid chromatography by use of a strong anion exchanger. Two oligosaccharide-alditols were obtained and their structures were identified by component analysis and 500-MHz 1H-NMR spectroscopy. The structures of the sugar chains were NeuAc alpha 2-3Gal beta 1-3GalNAcol and NeuAc alpha 2-3Gal beta 1-3(NeuAc alpha 2-6)GalNAcol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455710     DOI: 10.1093/oxfordjournals.jbchem.a122305

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

1.  Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected Peptides.

Authors:  Andrew G Roberts; Eric V Johnston; Jae-Hung Shieh; Joseph P Sondey; Ronald C Hendrickson; Malcolm A S Moore; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2015-10-01       Impact factor: 15.419

2.  Chinese hamster ovary cells continuously secrete a cysteine endopeptidase.

Authors:  M Satoh; S Hosoi; S Sato
Journal:  In Vitro Cell Dev Biol       Date:  1990-11

3.  Purification and characterization of two recombinant human granulocyte colony-stimulating factor glycoforms. Pharmacokinetic and activity studies of single-dose administration in mice.

Authors:  L Rotondaro; E De Paolis; D Ferrero; L D'Alatri; G Raucci; A Fabbri; G J Gerwig; J P Kamerling; M F Mariani; A Mele; R De Santis
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

4.  Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis.

Authors:  M Katano; M Nakamura; T Matsuo; A Iyama; T Hisatsugu
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

5.  Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) from rat nasal mucosa.

Authors:  M Machida; K Sano; M Arakawa; M Hayashi; S Awazu
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

6.  Optimization of cell culture conditions for G-CSF (granulocyte-colony stimulating factor) production by genetically engineered Namalwa KJM-1 cells.

Authors:  S Hosoi; K Murosumi; K Sasaki; M Satoh; H Miyaji; M Hasegawa; S Itoh; T Tamaoki; S Sato
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

Review 7.  Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)--what is the difference?

Authors:  M Höglund
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

8.  A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.

Authors:  C Whitehouse; J Burchell; S Gschmeissner; I Brockhausen; K O Lloyd; J Taylor-Papadimitriou
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

9.  Monitoring of the tissue distribution of fibroblast growth factor containing a high mannose-type sugar chain produced in mutant yeast.

Authors:  Shinji Takamatsu; Yasunori Chiba; Tomoko Ishii; Ken-ichi Nakayama; Tomoko Yokomatsu-Kubota; Tadashi Makino; Yasuhisa Fujibayashi; Yoshifumi Jigami
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

10.  Antiapoptotic effects of Phe140Asn, a novel human granulocyte colony-stimulating factor mutant in H9c2 rat cardiomyocytes.

Authors:  Hee Kyoung Chung; Eun Mi Ko; Sung Woo Kim; Sung-June Byun; Hak-Jae Chung; Moosik Kwon; Hwi-Cheul Lee; Byoung-Chul Yang; Deug-Woo Han; Jin-Ki Park; Sung-Gu Hong; Won-Kyong Chang; Kyung-Woon Kim
Journal:  BMB Rep       Date:  2012-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.